You are here: Events / Campus² Tech Talks – Smart Biomaterials
Language: ENG
Date: 10 Mar 2025
Time: 15:30 - 18:00
Entry fee: 0
Powered by Eindhoven University of Technology (Alumni Relations) & High Tech Campus Eindhoven.
📅 March 10, 2025
📍 High Tech Campus Eindhoven
🕞 15:30 – 18:00
Campus² Tech Talks: a new name, the same inspiring knowledge exchange
Formerly known as the Open Lecture, Campus² Tech Talks is the new platform where cutting-edge science meets real-world innovation. A collaboration between Eindhoven University of Technology (Alumni Relations) and High Tech Campus Eindhoven, this series connects academia and industry, offering fresh insights into the latest technological advancements.
This edition explores the power of Smart Biomaterials—a rapidly evolving field that is transforming healthcare, enabling new medical applications, and strengthening Brainport’s position as a global innovation hub. Experts from research and industry will shed light on the latest advances, from fundamental science to real-world applications, and the opportunities ahead. Register now!
🔹 Program
15.30 – 16.00 | Walk in
16.00 - 16.05 | Opening by Mercedes Tuin (moderator)
16.05 – 16.15 | Brainport: Global Leader in Biomaterials
Jan Rietsema, CEO, Smart BioMaterials Consortium
Brainport has the potential to be a global leader in smart biomaterials, driving innovation and economic growth. How can we leverage this to reduce high-tech reliance and accelerate medical breakthroughs?
16.15 – 16.35 | Revolutionizing Healthcare with Supramolecular Biomaterials
Professor Patricia Dankers, Eindhoven University of Technology
How fundamental research in biomaterials leads to groundbreaking biomedical applications.
16.35 – 16.45 | Tiny Scaffolds, Big Impact: Microgels in Tissue Engineering
Maritza Rovers, PhD, Dankers Laboratory
Cells rely on a gel-like environment for proper function. Learn how engineered microscopic hydrogels—microgels—can mimic this environment to support cell growth and tissue engineering.
16.45 – 16.55 | From Research to Reality: Transforming Science into Business
Bart Sanders, PhD, CEO, STENTiT
Turning a promising lab discovery into an approved vascular implant takes years of research, testing, and regulatory processes. Gain insights from STENTiT’s journey from concept to clinical application.
16.55 – 17.15 | Q&A Session (moderated by Mercedes Tuin, BOM Life Sciences & Med Tech)
17.15 – 18.00 | Drinks & Networking
We look forward to welcoming you!